Pharma Journalist -

SMi Group is proud to announce the 19th Annual Pain Therapeutics Conference is taking place at the Copthorne Tara Hotel in London, UK on the 13th and 14th May 2019. The global…
Read More...

ArQule, Inc.’s partner, Basilea Pharmaceutica announced that it entered into a collaboration with Roche to explore a combination of derazantinib (BAL087) and Roche’s PD-L1-blocking…
Read More...

Following the recent U.S Food and Drug Administration (FDA) approval of the Prior Approval Supplement (PAS) for second-generation Andexxa, Portola Pharmaceuticals, Inc. and Lonza…
Read More...

Ferring Pharmaceuticals (U.S.) announced that it has appointed Sophie Opdyke, Pharm.D., MBA as Vice President, General Manager, Oncology, effective immediately. She most recently served…
Read More...

Ironwood Pharmaceuticals announced the initiation of a Phase 1 study evaluating IW-6463 in healthy volunteers. IW-6463 is an orally administered central nervous system (CNS)-penetrant…
Read More...

Rigel Pharmaceuticals announced that it has entered into an exclusive license and supply agreement with Spain-based Grifols to commercialize fostamatinib disodium hexahydrate in all…
Read More...

CAMP4 Therapeutics announced a research collaboration with Alnylam Pharmaceuticals focused on identifying new druggable targets to address an undisclosed rare disease of the liver with…
Read More...

B-MoGen Biotechnologies and CytoSen Therapeutics announced a research collaboration to develop the next generation of gene-modified Natural Killer Cell (NK) therapies. B-MoGen will…
Read More...

BioNTech AG, a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases, and MAB…
Read More...

SMi is proud to announce the 3rd Annual 3D Cell Culture conference is returning to London in just four weeks’ time. Over the past few years, 3D Cell Culture has gained momentum…
Read More...